All Immuno Content

Bringing you the latest research in immuno-oncology, autoimmunity, therapeutic modalities and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Whitepaper
Nanion Technologies GmbH, Munich. TUM, Munich
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Uniquely designed for clinical research.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Welcome to the next level of live-cell analytics.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Next level live-cell kinetic and phenotypic assays.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Unprecedented flexibility for HTS automated patch clamp.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Comprehensive service overview for pharmaceutical partners
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Complex solutions delivered on time and within budget.
01 November 2023
Biomarkers in Immuno-Oncology
Whitepaper
Global leaders in specialist biomarker and bioanalysis research services.
01 November 2023
Biomarkers in Immuno-Oncology

Search by Keyword

Filter by Subject Area

Immuno Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)